Fund shareholders of Crinetics Pharmaceuticals Inc
ISIN US22663K1079 · United States · LEI 549300Q1CNFXK5P31D28
- Fund shareholders
- 308
- Of which ETFs
- 57 251 other funds
- Value held
- 2B $ 84.2M SEK · 28.9K €
- Share of capital
- 49.8 % of 106.1M shares on Jul 22, 2026
308 funds hold this company. This table lists the 307 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares Hedge Replication ETF ProShares Trust | 100 | 4.1K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 82 | 3.4K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 55 | 2.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 32 | 1.3K $ | 0.12 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 26 | 944.3 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 14 | 575.4 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 28.9K € | 0.79 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 2.52 % | as of Feb 28, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.37 % | as of Sep 30, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.88 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.81 % | as of Mar 31, 2026 ↗ |
| Driehaus Small/Mid Cap Growth Fund Driehaus Mutual Funds | 1.74 % | as of Mar 31, 2026 ↗ |
| Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I | 1.72 % | as of Mar 31, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 1.71 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.40 % | as of Apr 30, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 1.39 % | as of Mar 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.38 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 304 | +8 | 52,602,028 | +8.0 % |
| 2026Q1 | 296 | +15 | 48,716,535 | +3.3 % |
| 2025Q4 | 281 | -3 | 47,158,808 | -1.0 % |
| 2025Q3 | 284 | -8 | 47,658,707 | -0.2 % |
| 2025Q2 | 292 | -29 | 47,760,969 | +6.2 % |
| 2025Q1 | 321 | +12 | 44,977,519 | +16.5 % |
| 2024Q4 | 309 | +7 | 38,612,671 | +23.1 % |
| 2024Q3 | 302 | +18 | 31,364,355 | +13.3 % |
| 2024Q2 | 284 | +35 | 27,676,482 | +3.8 % |
| 2024Q1 | 249 | +32 | 26,662,666 | +18.8 % |
| 2023Q4 | 217 | 22,445,595 |
Institutional managers
233 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 15,759,799 | 572.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 8,478,815 | 308M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 8,338,098 | 302.8M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 8,157,204 | 296.3M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 6,395,922 | 232.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5,355,496 | 194.5K $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 4,520,251 | 164.2M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 4,288,120 | 155.7M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 3,280,000 | 119.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,480,763 | 90.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,403,046 | 87.3M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 2,351,465 | 85.4M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,940,622 | 70.5K $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 1,903,636 | 69.1M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,884,281 | 68.2M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,716,445 | 62.3M $ | as of Mar 31, 2026 |
| GW&K Investment Management, LLC | 1,618,686 | 58.8K $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 1,550,000 | 56.3M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,451,326 | 52.7M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 1,324,668 | 45.4M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,139,331 | 41.4M $ | as of Mar 31, 2026 |
| First Light Asset Management, LLC | 1,089,670 | 39.6M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,052,858 | 38.2M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,043,879 | 37.9M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 999,000 | 36.3M $ | as of Mar 31, 2026 |
Declared shareholders of Crinetics Pharmaceuticals Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Wellington Management Group LLP and 3 others | 7.80 % | 8,157,204 | as of Mar 31, 2026 · SCHEDULE 13G |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 6.11 % | 6,395,922 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.19 % | 5,440,646 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Associates, Inc. | 5.10 % | 5,355,011 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Crinetics Pharmaceuticals Inc". https://titelia.com/en/stocks/crinetics-pharmaceuticals-inc-US22663K1079